| CAS No. | 1019206-88-2 |
|---|---|
| MDL No. | MFCD17170366 |
| MF | C21H17ClF4N4O4 |
| MW | 500.80 |
| InChI Key | ZOPOQLDXFHBOIH-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 100 mg | 98% | $8 | In Stock | |
| 250 mg | 98% | $12 | In Stock | |
| 1 g | 98% | $21 | In Stock | |
| 5 g | 98% | $70 | In Stock | |
| 10 g | 98% | $116 | In Stock | |
| 25 g | 98% | $229 | In Stock | |
| 100 g | 98% | $603 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Regorafenib hydrate is the monohydrate form of anhydrous regorafenib. It is used in the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR, or anti-VEGF therapy. It functions as an antineoplastic agent, tyrosine kinase inhibitor, and hepatotoxic agent. It contains regorafenib.
| CAS No. | 1019206-88-2 |
|---|---|
| Product Name | Regorafenib Monohydrate |
Health Hazard
Environmental Hazard
